To test, or not to test, and how … copeptin, please advise!

Jonas Rutishauser

doi:10.4414/smw.2020.20292

Viewpoint

Vol. 150 No. 2930 (2020)

To test, or not to test, and how … copeptin, please advise!

Jonas Rutishauser

DOI: https://doi.org/10.4414/smw.2020.20292
Cite this as:: Swiss Med Wkly. 2020;150:w20292
Published: 22.07.2020

References

Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH. Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med. 1970;73(5):721–9. doi:.https://doi.org/10.7326/0003-4819-73-5-721
Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med. 1981;305(26):1539–46. doi:.https://doi.org/10.1056/NEJM198112243052601
Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112–9. doi:.https://doi.org/10.1373/clinchem.2005.060038
Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab. 2011;96(4):1046–52. doi:.https://doi.org/10.1210/jc.2010-2499
Refardt J, Christ-Crain M. Copeptin-based diagnosis of diabetes insipidus. Swiss Med Wkly. 2020;150:w20237. doi:.https://doi.org/smw.2020.20237

Publication image

How to Cite

1.

Rutishauser J. To test, or not to test, and how … copeptin, please advise!. Swiss Med Wkly [Internet]. 2020 Jul. 22 [cited 2024 Nov. 21];150(2930):w20292. Available from: https://smw.ch/index.php/smw/article/view/2837

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Jonas Rutishauser, Statins in clinical medicine , Swiss Medical Weekly: Vol. 141 No. 4748 (2011)
Jonathan Benhamou, Christian Schindler, Jonas Rutishauser, Prevalence of vitamin D deficiency in an inpatient population in the Swiss Canton of Basel-Country , Swiss Medical Weekly: Vol. 151 No. 0910 (2021)
Brigitte Engel, Christian Schindler, Jörg D. Leuppi, Jonas Rutishauser, Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial , Swiss Medical Weekly: Vol. 147 No. 1920 (2017)
Jonas Rutishauser, The role of statins in clinical medicine -LDL - cholesterol lowering and beyond , Swiss Medical Weekly: Vol. 136 No. 0304 (2006)
Konstantin Burgmann, Sandra A. Fatio, Beat Jordi, Jonas Rutishauser, Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis , Swiss Medical Weekly: Vol. 143 No. 4344 (2013)

[1] Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH. Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med. 1970;73(5):721–9. doi:.https://doi.org/10.7326/0003-4819-73-5-721

[2] Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med. 1981;305(26):1539–46. doi:.https://doi.org/10.1056/NEJM198112243052601

[3] Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112–9. doi:.https://doi.org/10.1373/clinchem.2005.060038

[4] Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab. 2011;96(4):1046–52. doi:.https://doi.org/10.1210/jc.2010-2499

[5] Refardt J, Christ-Crain M. Copeptin-based diagnosis of diabetes insipidus. Swiss Med Wkly. 2020;150:w20237. doi:.https://doi.org/smw.2020.20237